1. LC-MS Quantification of Malondialdehyde-Dansylhydrazine Derivatives in Urine and Serum Samples
- Author
-
Kostya Kartavenka, Volha Yakimavets, Parinya Panuwet, P. Barry Ryan, Priya E. D’Souza, Churdsak Jaikang, Kanitarin Thipubon, and Dana B. Barr
- Subjects
Health, Toxicology and Mutagenesis ,Electrospray ionization ,Urine ,Toxicology ,01 natural sciences ,Article ,Analytical Chemistry ,03 medical and health sciences ,chemistry.chemical_compound ,Limit of Detection ,Tandem Mass Spectrometry ,Liquid chromatography–mass spectrometry ,Malondialdehyde ,Humans ,Environmental Chemistry ,Derivatization ,Quadrupole mass analyzer ,Chromatography, High Pressure Liquid ,030304 developmental biology ,Dansyl Compounds ,0303 health sciences ,Chemical Health and Safety ,Chromatography ,010401 analytical chemistry ,Serum samples ,Body Fluids ,0104 chemical sciences ,Hydrazines ,chemistry ,Reagent ,Chromatography, Liquid - Abstract
We developed a robust analytical method for quantification of malondialdehyde (MDA) in urine and serum samples using dansylhydrazine (DH) as a derivatizing reagent. The derivatization procedure was partially carried out using an autosampler injection program to minimize errors associated with the low-volume addition of reagents and was optimized to yield a stable hydrazone derivative of MDA and its labeled d2-MDA analogue. The target MDA-DH derivatives were separated on an Agilent Zorbax Eclipse Plus Phenyl-Hexyl (3.0 × 100 mm, 3.5 μm) column. The mass-to-charge ratios of the target derivatives [(M+H)+ of 302 and 304 for MDA-DH and d2-MDA-DH, respectively] were analyzed in single ion monitoring mode using a single quadrupole mass spectrometer operated under positive electrospray ionization. The method limits of quantification were 5.63 nM (or 0.405 ng/mL) for urine analysis and 5.68 nM (or 0.409 ng/mL) for serum analysis. The quantification range for urine analysis was 5.63–500 nM (0.405–36.0 ng/mL) while the quantification range for serum analysis was 5.68–341 nM (0.409–24.6 ng/mL). The method showed good relative recoveries (98–103%), good accuracies (92–98%), and acceptable precisions (relative standard deviations 1.8–7.3% for inter-day precision; 1.8–6.1% for intra-day precision) as observed from the repeat analysis of quality control samples prepared at different concentrations. The method was used to measure MDA in individual urine samples (n = 287) and de-identified archived serum samples (n = 22) to assess the overall performance of the method. The results demonstrated that our method is capable of measuring urinary and serum levels of MDA, allowing its future application in epidemiologic investigations.
- Published
- 2020
- Full Text
- View/download PDF